164 related articles for article (PubMed ID: 8401618)
1. [The value of antibiotic prophylaxis in transurethral resection of bladder tumors. Apropos of 61 cases].
Delavierre D; Huiban B; Fournier G; Le Gall G; Tande D; Mangin P
Prog Urol; 1993; 3(4):577-82. PubMed ID: 8401618
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.
Wagenlehner FM; Wagenlehner C; Schinzel S; Naber KG;
Eur Urol; 2005 Apr; 47(4):549-56. PubMed ID: 15774257
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic prophylaxis in transurethral surgery. Ceftriaxone versus cephradine versus control. A randomized, prospective study in low risk patients.
Thorsteinsson SB; Einarsson GV; Steingrimsson O; Jensen RH
Scand J Infect Dis Suppl; 1990; 70():68-73. PubMed ID: 2287905
[TBL] [Abstract][Full Text] [Related]
4. Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma.
Li LY; Yang M; Zhang HB; Su XK; Xu WF; Chen Y; Shen ZJ; Gao X
BJU Int; 2008 Aug; 102(5):566-71. PubMed ID: 18410436
[TBL] [Abstract][Full Text] [Related]
5. Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: a feasibility study.
Yokoyama M; Fujii Y; Yoshida S; Saito K; Koga F; Masuda H; Kobayashi T; Kawakami S; Kihara K
Int J Urol; 2009 Jan; 16(1):61-3. PubMed ID: 19120528
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of two protocols of antibiotic prophylaxis in endoscopic urologic surgery].
Lepage JY; Malinowsky JM; Cozian A; Viers MF; Rolland MT; Péron M; Souron R; Baron D
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):564-7. PubMed ID: 2200997
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial prophylaxis in urologic endoscopic surgery: pefloxacin versus ceftriaxone].
Osca García JM; Broseta Rico E; Ruiz Cerda JL; García Reboll L; Morera Martínez J; Martínez Jabaloyas JM; Jiménez Cruz JF
Actas Urol Esp; 1993 Sep; 17(8):483-6. PubMed ID: 8237525
[TBL] [Abstract][Full Text] [Related]
8. [Antibiotics in transurethral resection of the prostate in patients with low risk of infectious complications: randomized prospective comparative study].
Valdevenito Sepúlveda JP
Arch Esp Urol; 2004; 57(1):48-57. PubMed ID: 15112871
[TBL] [Abstract][Full Text] [Related]
9. [Infectious complications after transurethral resection].
Pestalozzi DM; Böss HP; Knönagel H
Helv Chir Acta; 1992 Oct; 59(3):497-500. PubMed ID: 1281466
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Prophylaxis for Postoperative Urinary Tract Infections in Transurethral Resection of Bladder Tumors: A Systematic Review and Meta-Analysis.
Bausch K; Halbeisen FS; Aghlmandi S; Sutter SU; Ewald H; Appenzeller-Herzog C; Roth JA; Widmer AF; Seifert HH
J Urol; 2021 Apr; 205(4):987-998. PubMed ID: 33284673
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S
J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865
[TBL] [Abstract][Full Text] [Related]
12. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?
Divrik T; Yildirim U; Eroğlu AS; Zorlu F; Ozen H
J Urol; 2006 Apr; 175(4):1258-61. PubMed ID: 16515974
[TBL] [Abstract][Full Text] [Related]
13. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
14. A prospective randomized and placebo-controlled study for the evaluation of antibiotic prophylaxis in transurethral resection of the prostate.
Ozturk M; Koca O; Kaya C; Karaman MI
Urol Int; 2007; 79(1):37-40. PubMed ID: 17627166
[TBL] [Abstract][Full Text] [Related]
15. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
[TBL] [Abstract][Full Text] [Related]
16. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
17. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
18. Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery.
Klimberg IW; Malek GH; Cox CE; Patterson AL; Whalen E; Kowalsky SF; Echols RM
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():77-84. PubMed ID: 10225576
[TBL] [Abstract][Full Text] [Related]
19. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.
Sadek S; Soloway MS; Hook S; Civantos F
J Urol; 1999 Jan; 161(1):77-9; discussion 79-80. PubMed ID: 10037373
[TBL] [Abstract][Full Text] [Related]
20. Ceftriaxone in the prevention of postoperative infection in patients undergoing transurethral resection of the prostate.
Finkelstein LH; Arsht DB; Manfrey SJ; Childs S
Am J Surg; 1984 Oct; 148(4A):19-21. PubMed ID: 6091475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
